United States: First High-Concentration Humira® Interchangeable, Alvotech And Teva's Simlandi®, Approved In The U.S. - Venable LLP
Monday, 11 March 2024
On February 23, 2024, the FDA approved Alvotech and Teva's Simlandi® (adalimumab-ryvk) as biosimilar to and interchangeable with AbbVie's Humira® (adalimumab). Simlandi® is the tenth Humira...
|
||||
You Might Like |
||||
